CS221818B2 - Method of making the derivatives of the 1-/cyclohexyl/-4-aryl-4-piperidine with the cyano group and aryl group,bound in position 4 cyclohexyl ring - Google Patents
Method of making the derivatives of the 1-/cyclohexyl/-4-aryl-4-piperidine with the cyano group and aryl group,bound in position 4 cyclohexyl ring Download PDFInfo
- Publication number
- CS221818B2 CS221818B2 CS81435A CS43581A CS221818B2 CS 221818 B2 CS221818 B2 CS 221818B2 CS 81435 A CS81435 A CS 81435A CS 43581 A CS43581 A CS 43581A CS 221818 B2 CS221818 B2 CS 221818B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- parts
- formula
- group
- acid
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11492480A | 1980-01-24 | 1980-01-24 | |
US06/191,631 US4369184A (en) | 1980-01-24 | 1980-09-29 | 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS221818B2 true CS221818B2 (en) | 1983-04-29 |
Family
ID=26812674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS81435A CS221818B2 (en) | 1980-01-24 | 1981-01-21 | Method of making the derivatives of the 1-/cyclohexyl/-4-aryl-4-piperidine with the cyano group and aryl group,bound in position 4 cyclohexyl ring |
Country Status (25)
Country | Link |
---|---|
US (1) | US4369184A (es) |
EP (1) | EP0034415B1 (es) |
AU (1) | AU538130B2 (es) |
BG (2) | BG35465A3 (es) |
CA (1) | CA1187080A (es) |
CS (1) | CS221818B2 (es) |
DE (1) | DE3163787D1 (es) |
DK (1) | DK152670C (es) |
ES (2) | ES498793A0 (es) |
FI (1) | FI76562C (es) |
GR (1) | GR71898B (es) |
HK (1) | HK81088A (es) |
HU (1) | HU183293B (es) |
IE (1) | IE50706B1 (es) |
IL (1) | IL61968A (es) |
LU (1) | LU88220I2 (es) |
MA (1) | MA19046A1 (es) |
MY (1) | MY8700593A (es) |
NL (1) | NL930017I2 (es) |
NO (1) | NO1994012I1 (es) |
NZ (1) | NZ196117A (es) |
PH (1) | PH16611A (es) |
PL (2) | PL127483B1 (es) |
SU (1) | SU1230467A3 (es) |
YU (1) | YU48446B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6322584A (ja) * | 1986-07-15 | 1988-01-30 | Senjiyu Seiyaku Kk | 1−ハイドロキシ−5−オキソ−5H−ピリド〔3,2−a〕フエノキサジン−3−カルボン酸エステル類 |
DE4108527A1 (de) * | 1991-03-15 | 1992-09-17 | Basf Ag | Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung |
AU1716995A (en) * | 1994-03-18 | 1995-10-09 | Ciba-Geigy Ag | Aqueous solution of levocabastine for ophthalmic use |
US5661163A (en) * | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
DE69733664T3 (de) | 1996-04-19 | 2011-04-14 | Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles | Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen |
US6267986B1 (en) | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
US20020146409A1 (en) * | 2001-01-30 | 2002-10-10 | Herring Steven W. | Methods for stabilizing lyophilized blood proteins |
WO2004019955A1 (en) | 2002-08-30 | 2004-03-11 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
ES2594156T3 (es) | 2006-01-06 | 2016-12-16 | Sunovion Pharmaceuticals Inc. | Cicloalquilaminas como inhibidores de la recaptación de monoaminas |
CA2653953C (en) | 2006-06-01 | 2015-12-08 | Schering-Plough Healthcare Products, Inc. | Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
NZ573174A (en) | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
EP2234597A1 (en) * | 2007-12-21 | 2010-10-06 | Schering-Plough Healthcare Products, Inc. | Enhancing photostabilization of oxymetazoline |
WO2013072705A1 (en) | 2011-11-18 | 2013-05-23 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
US10259787B2 (en) | 2016-10-14 | 2019-04-16 | Heptares Therapeutics Limited | Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1206436B (de) * | 1957-07-05 | 1965-12-09 | Janssen Pharmaceutica Nv | Verfahren zur Herstellung von Derivaten von 2, 2-Diaryl-4-(4'-phenyl-piperidino)-butyronitrilen |
NL127792C (es) * | 1965-06-29 |
-
1980
- 1980-09-29 US US06/191,631 patent/US4369184A/en not_active Expired - Lifetime
-
1981
- 1981-01-08 GR GR63814A patent/GR71898B/el unknown
- 1981-01-16 AU AU66255/81A patent/AU538130B2/en not_active Expired
- 1981-01-21 CS CS81435A patent/CS221818B2/cs unknown
- 1981-01-22 MA MA19247A patent/MA19046A1/fr unknown
- 1981-01-22 PH PH25120A patent/PH16611A/en unknown
- 1981-01-22 DK DK029381A patent/DK152670C/da not_active IP Right Cessation
- 1981-01-23 IL IL61968A patent/IL61968A/xx not_active IP Right Cessation
- 1981-01-23 BG BG8150518A patent/BG35465A3/xx unknown
- 1981-01-23 PL PL1981233921A patent/PL127483B1/pl unknown
- 1981-01-23 DE DE8181300313T patent/DE3163787D1/de not_active Expired
- 1981-01-23 HU HU81148A patent/HU183293B/hu unknown
- 1981-01-23 PL PL1981229365A patent/PL127679B1/pl unknown
- 1981-01-23 ES ES498793A patent/ES498793A0/es active Granted
- 1981-01-23 SU SU813233002A patent/SU1230467A3/ru active
- 1981-01-23 IE IE125/81A patent/IE50706B1/en not_active IP Right Cessation
- 1981-01-23 YU YU18381A patent/YU48446B/sh unknown
- 1981-01-23 EP EP81300313A patent/EP0034415B1/en not_active Expired
- 1981-01-23 LU LU88220C patent/LU88220I2/xx unknown
- 1981-01-23 FI FI810193A patent/FI76562C/fi not_active IP Right Cessation
- 1981-01-23 CA CA000369180A patent/CA1187080A/en not_active Expired
- 1981-01-26 NZ NZ196117A patent/NZ196117A/en unknown
- 1981-12-30 ES ES508441A patent/ES508441A0/es active Granted
-
1987
- 1987-12-30 MY MY593/87A patent/MY8700593A/xx unknown
-
1988
- 1988-10-06 HK HK810/88A patent/HK81088A/xx not_active IP Right Cessation
-
1993
- 1993-03-02 NL NL930017C patent/NL930017I2/nl unknown
- 1993-06-16 BG BG97872A patent/BG60472B2/bg unknown
-
1994
- 1994-08-30 NO NO1994012C patent/NO1994012I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS221818B2 (en) | Method of making the derivatives of the 1-/cyclohexyl/-4-aryl-4-piperidine with the cyano group and aryl group,bound in position 4 cyclohexyl ring | |
EP0040639B1 (en) | Isoxazole derivatives | |
FI82242B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(piperidinyl)-1h-indazolderivat. | |
AU2001242744B2 (en) | Diphenylalkylamine derivatives useful as opioid delta receptor ligands | |
JP3056321B2 (ja) | ピペリジン誘導体 | |
US3978045A (en) | N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof | |
HU179734B (en) | Process for producing pharmaceutically effective new n-2 above-bracket-1,2,3,4-tetrahydro-8-quinolyl-bracket closed-sulfonyl-l-arginine-amides | |
EA007225B1 (ru) | Производные n-[фенил(пиперидин-2-ил)метил]бензамида и их применение в терапии | |
EP0258755A1 (en) | Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments | |
EP0374801A2 (en) | Novel N-sustituted azaheterocyclic carboxylic acids | |
JPS63146874A (ja) | インドール誘導体 | |
HU187777B (en) | Process for preparing pyrrolidine derivatives | |
EP0068331B1 (en) | Tetrahydrofuran compounds and analogs thereof | |
US3974158A (en) | 2-(Substituted anilino)methylmorpholines | |
HU202211B (en) | Process for producing new imidazoline derivatives and pharmaceutical compositions containing them as active components | |
SU1093251A3 (ru) | Способ получени производных 4 @ -пиридо(1,2-а)пиримидин-4-она или их фармацевтически приемлемых кислотно-аддитивных солей | |
HU211864A9 (en) | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | |
HU182941B (en) | Process for preparing new n-oxacyclyl-alkyl-piperidines further pharmaceutical compositions containing these compounds | |
FI71936B (fi) | Foerfarande foer framstaellning av neuroleptiskt aktiva 2-substituerade-8-fluor-5-(4-fluorfenyl)-2,3,4,4a 5,9b-hexahydro-4a 9b-trans-1h-pyrido/4,3-b/indolderivat | |
FI90070B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva derivat av 1,2,5,6-tetrahydropyridin-3-karboxaldehydoxim | |
KR870001681B1 (ko) | 히단토인 유도체의 제조방법 | |
US4029786A (en) | Morpholine derivatives for treating depression | |
CH644364A5 (de) | 4-(naphthalinyloxy)piperidin-derivate. | |
US4002618A (en) | 2,2-Diphenyl-5-(4-substituted-piperidino)-3-trans-pentenenitriles | |
US4622327A (en) | 2H-azeto[2,1-a]-isoquinoline derivatives and pharmaceutical compositions containing them |